Insider Transactions in Q1 2021 at Wave Life Sciences Ltd. (WVE)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 24
2021
|
Kyle Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,930
+11.92%
|
$21,860
$2.48 P/Share
|
Feb 16
2021
|
Kyle Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,722
-2.41%
|
$17,220
$10.57 P/Share
|
Feb 16
2021
|
Chandra Vargeese |
SELL
Open market or private sale
|
Direct |
3,145
-3.55%
|
$31,450
$10.57 P/Share
|
Feb 16
2021
|
Michael A. Panzara Officer |
SELL
Open market or private sale
|
Direct |
2,929
-3.28%
|
$29,290
$10.57 P/Share
|
Feb 16
2021
|
Paul Bolno President and CEO |
SELL
Open market or private sale
|
Direct |
11,205
-2.65%
|
$112,050
$10.57 P/Share
|
Feb 16
2021
|
Chris Francis |
SELL
Open market or private sale
|
Direct |
2,698
-3.32%
|
$26,980
$10.57 P/Share
|
Feb 01
2021
|
Kyle Moran Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+41.12%
|
-
|
Feb 01
2021
|
Chandra Vargeese |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+36.09%
|
-
|
Feb 01
2021
|
Michael A. Panzara Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+35.88%
|
-
|
Feb 01
2021
|
Paul Bolno President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+26.22%
|
-
|
Feb 01
2021
|
Chris Francis |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.12%
|
-
|